on the advice of the Minister of Health tendered after consultation with the organisations or bodies appearing to the Minister to be representative of persons likely to be substantially affected by the regulations.

1	Title
2	Commencement
3	Principal regulations
4	Regulation 3 amended (Interpretation)
5	Regulation 8 amended (Functions of issuer)
	Explanatory note
	Administrative Information

Regulations

1 Title

These regulations are the Medicines (Standing Order) Amendment Regulations 2016.

2 Commencement

These regulations come into force on 17 August 2016.

3 Principal regulations

These regulations amend the Medicines (Standing Order) Regulations 2002 (the principal regulations).

4 Regulation 3 amended (Interpretation)

(1)

In regulation 3(1), definition of issuer, paragraph (d), after “behalf”, insert “; or”.

(2)

In regulation 3(1), definition of issuer, after paragraph (d), insert:

(e)

a nurse practitioner (whether an individual in practice or otherwise); or

(f)

an optometrist (whether an individual in practice or otherwise)

5 Regulation 8 amended (Functions of issuer)

Replace regulation 8(a)(v) with:

(v)

the standing order is made available to every person permitted to supply or administer a medicine under the standing order, any person affected by the standing order, and, on request to the issuer, any other person; and

Rachel Hayward,
for Clerk of the Executive Council.

Explanatory note

This note is not part of the regulations, but is intended to indicate their general effect.

These regulations, which come into force on 17 August 2016, amend the Medicines (Standing Order) Regulations 2002 by extending the definition of issuer to include nurse practitioners and optometrists (as defined in the Medicines Act 1981). The main effect of this change is that nurse practitioners and prescribing optometrists can issue standing orders so that other health professionals may administer and supply prescription medicine under those standing orders. The requirements for issuers to make standing orders available are also simplified in line with current practice.

Regulatory impact statement

The Ministry of Health produced a regulatory impact statement on 21 March 2016 to help inform the decisions taken by the Government relating to the contents of this instrument.

A copy of this regulatory impact statement can be found at—

Issued under the authority of the Legislation Act 2012.

Date of notification in Gazette: 14 July 2016.

These regulations are administered by the Ministry of Health.

Medicines (Standing Order) Amendment Regulations 2016